Join
Live feed
·
INSIDERFilingvia Quantisnow
Whitehawk Therapeutics Inc. logo

Director Castelein Caley was granted 255,102 shares, increasing direct ownership by 1,295% to 274,796 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
WHWK· Whitehawk Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track WHWK (Whitehawk Therapeutics Inc.) and more on Quantisnow.